Personalized High-Rate Fluid Removal Guided by Ultrasound in Hospitalized ESRD with Fluid Overload
Official title: FluId removaL With a High Rate ulTRAfiltration Protocol in paTiEnts With Intravascular Congestion: the FILTRATE Trial
Run by Universidad Autonoma de Nuevo Leon · NCT07705269 · Data updated 2026-11-12
This trial tests whether using ultrasound to guide a higher rate of fluid removal is as safe and effective as standard fluid removal for adults with end-stage kidney disease who are admitted for severe fluid overload.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Universidad Autonoma de Nuevo Leon Academic / other |
| Locations | 1 site (Monterrey, Nuevo León) |
| Status | Recruiting |
| Started | June 4, 2026 |
| Main results expected | June 2027 |
| Study ends | October 2027 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT07705269 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with end-stage kidney disease on chronic hemodialysis admitted for acute fluid overload and ultrasound-confirmed severe intravascular congestion, who are hemodynamically stable.
✕Probably not a fit
Patients with low baseline blood pressure, shock, acute coronary syndrome, severe valvular disease, or other excluded conditions may not benefit and could be at higher risk.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares a personalized, ultrasound-guided high-rate ultrafiltration strategy to standard fluid removal in adults with end-stage renal disease requiring hospital-based fluid removal for acute congestion. Ultrasound techniques, including lung ultrasound and VExUS, are used to identify patients with severe intravascular congestion and guide treatment. The goal is to determine if rapid fluid removal can relieve symptoms without increasing risk compared with conventional rates. The study is conducted at a tertiary center in Monterrey, with collaboration between Universidad Autonoma de Nuevo Leon and Hospital Universitario Dr. Jose E. Gonzalez. Participants are adults on long-term hemodialysis, hemodynamically stable at baseline, and meeting ultrasound-confirmed congestion criteria.
Why it matters
Potential benefit: If successful, patients could experience quicker relief from congestion with a safe, personalized fluid removal approach.
How similar studies have gone: Previous practices often use higher ultrafiltration rates outside guidelines, but rigorous ultrasound-guided testing of this approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults over 18 years old with End-Stage Renal Disease on hemodialysis for at least 3 months. * Admitted to the hospital requiring mechanical fluid removal for acute fluid overload (first in-hospital session). * Clear ultrasound evidence of severe intravascular congestion (such as diffuse B-lines in the lungs or altered VExUS vascular flow patterns). * Hemodynamically stable with a baseline blood pressure of at least 120/80 mmHg. Exclusion Criteria: * Baseline low blood pressure (\<100/60 mmHg) or active shock (cardiogenic, septic, or distributive). * Acute coronary syndrome (heart attack), severe heart valve disease, or severe fluid around the heart. * Known chronic lung disease. * Pregnancy.
Where it's running
-
Hospital Universitario "Dr. José E. González"
Monterrey, Nuevo León, Mexico Recruiting
Study contacts
- Study coordinator: Edgar Adrián Montemayor, Nephrology Fellow
- Email: edgar.montemayorga@uanl.edu.mx
- Phone: +52 8180911271
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using a bioimpedance device to track fluid status in children after stem cell transplant
The study tests whether bedside bioimpedance measurements can reliably track body water changes in children undergoing stem cell transplantation, alongside standard fluid checks.
-
Understanding how patients tolerate fluid removal during kidney support in the ICU
This observational study tests how well critically ill adults with acute kidney injury tolerate net fluid removal during continuous renal replacement therapy.
-
Electric cardiometry-guided fluid therapy during robotic prostatectomy
This study tests whether using an electrical cardiometry device to guide fluid administration during robotic prostatectomy improves patient care compared with a standard fluid approach.
-
Choosing dialysis: what matters most to patients
This project uses a questionnaire to see which factors, including possible financial compensation, influence dialysis choices among adults with advanced kidney failure who are considering dialysis options.
-
Dapagliflozin for people on chronic peritoneal dialysis
This will give dapagliflozin 10 mg once daily for six months to people with end-stage kidney disease on chronic peritoneal dialysis to see if it increases fluid removal and urine output.
-
Storing deceased donor kidneys at 10°C instead of on ice (4°C)
This trial will try to see if deceased donor kidneys stored at 10°C help adult transplant recipients have better kidney function after transplant compared with kidneys stored on ice (4°C).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.